Search - tctmd.com

Displaying 221 - 240 of 319

Sort: Relevancy | Date

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Daily News

High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals

Lucy Hicks

August 21, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Daily News

Uphill Climb Seen for Implementation of US Blood Pressure Guidelines

Todd Neale

July 12, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Daily News

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

L.A. McKeown

May 23, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Daily News

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Michael O'Riordan

April 16, 2018

News Daily News

Supplemental Oxygen Not Beneficial in MI Patients With Normal O2 Levels: Meta-analysis

Michael O'Riordan

April 11, 2018

News Daily News

Physical Activity Conversations With Patients Need to Be Routine, AHA Says

Todd Neale

April 06, 2018

News Conference News ACC 2018

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Michael O'Riordan

March 15, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Daily News

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Michael O'Riordan

March 06, 2018

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

L.A. McKeown

February 26, 2018

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

News Daily News

Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy

Yael L. Maxwell

January 29, 2018

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

L.A. McKeown

January 22, 2018

News Daily News

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Shelley Wood

January 17, 2018

Advertisement

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Uphill Climb Seen for Implementation of US Blood Pressure Guidelines

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Supplemental Oxygen Not Beneficial in MI Patients With Normal O2 Levels: Meta-analysis

Physical Activity Conversations With Patients Need to Be Routine, AHA Says

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Ticagrelor: Better Platelet Blockade Post-TAVR?

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content